APROKAM is a pharmaceutical product primarily used in the field of ophthalmology. It contains cefuroxime, a second-generation cephalosporin antibiotic, as its active ingredient. APROKAM is specifically designed for intracameral administration, which means it is injected directly into the anterior chamber of the eye. This method of delivery is commonly employed during cataract surgery to prevent postoperative infections, such as endophthalmitis, which can lead to severe complications if not properly managed. The use of APROKAM has become a standard prophylactic measure in many surgical protocols due to its effectiveness in reducing the risk of bacterial infections following cataract extraction procedures.